News Release Archive
HEALTH--NOVA SCOTIA'S NEW FORMULARY FIRST OF ITS KIND IN CANADA ----------------------------------------------------------------- The Department of Health, in cooperation with physicians, pharmacists and seniors, is providing an innovative approach to disease management with a new formulary -- a medical/pharmaceutical resource tool -- scheduled to be released in mid-June. The new formulary will be the first of its kind in Canada. It will follow the ATC (Anatomical, Therapeutic, Chemical) classification system and serve as a comprehensive resource tool for physicians and pharmacists. It will feature more than 100 treatment summaries written by local physicians, drug listings, and indicators of comparative drug costs. "Nova Scotia's formulary is a creative and effective solution to meet the challenge of increasing prescription drug costs," said Health Minister Ron Stewart. "Physicians and pharmacists alike will now have a key reference source which will highlight prescribing information to assist them as they continue to provide quality patient care." Currently physicians and pharmacists may need to consult several documents before selecting the best drug therapy. Through a coding system, the new formulary will allow them to quickly review treatment options for a specific medical condition. Comparative costs will also be highlighted. This will help to ensure the most beneficial medication is being prescribed for the patients while at the same time managing costs. The formulary, which will be updated regularly, will also indicate which drugs are covered under the Seniors' Pharmacare and Family Benefits programs. The ATC classification system is used by the World Health Organization and the Patented Medicine Prices Review Board. It divides the formulary into 14 major anatomical categories. In each anatomical category, the drugs are listed according to therapeutic categories and subcategories. Within each therapeutic category, the drugs are listed alphabetically by generic name according to chemical classification. The new formulary is a direct result of recommendations made by the 1994 Nova Scotia Pharmacare Reform Working Group. In response, the formulary was developed by representatives from the Nova Scotia Department of Health, Senior Citizens' Secretariat, Dalhousie Family Medicine, Dalhousie College of Pharmacy, Medical Society of Nova Scotia, Nova Scotia Pharmaceutical Society, Canadian Drug Manufacturers Association and the Pharmaceutical Manufacturers Association of Canada. A working copy of Nova Scotia's new formulary is at the Medical Society of Nova Scotia's annual meeting at the World Trade and Convention Centre this weekend. -30- Contact: Sue McKeage 902-424-3581 trp May 10, 1996 - 2:30 p.m.